Organometallic Antitumor Compounds: Ferrocifens as Precursors to Quinone Methides

Angew Chem Int Ed Engl. 2015 Aug 24;54(35):10230-3. doi: 10.1002/anie.201503048. Epub 2015 Jul 14.

Abstract

The synthesis and chemical oxidation profile of a new generation of ferrocifen derivatives with strong antiproliferative behavior in vitro is reported. In particular, the hydroxypropyl derivative HO(CH2 )3 C(Fc)=C(C6 H4 OH)2 (3 b) exhibited exceptional antiproliferative activity against the cancer cell lines HepG2 and MDA-MB-231 TNBC, with IC50 values of 0.07 and 0.11 μM, respectively. Chemical oxidation of 3 b yielded an unprecedented tetrahydrofuran-substituted quinone methide (QM) via internal cyclization of the hydroxyalkyl chain, whereas the corresponding alkyl analogue CH3 CH2 -C(Fc)=C(C6 H4 OH)2 merely formed a vinyl QM. The ferrocenyl group in 3 b plays a key role, not only as an intramolecular reversible redox "antenna", but also as a stabilized carbenium ion "modulator". The presence of the oxygen heterocycle in 3 b-QM enhances its stability and leads to a unique chemical oxidation profile, thus revealing crucial clues for deciphering its mechanism of action in vivo.

Keywords: antitumor agents; drug discovery; ferrocene; metabolism; quinones.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Proliferation / drug effects*
  • Chromatography, High Pressure Liquid
  • Cyclization
  • Ferrous Compounds / chemistry
  • Ferrous Compounds / pharmacology*
  • Hep G2 Cells
  • Humans
  • Indolequinones / chemistry*
  • Organometallic Compounds / chemistry
  • Organometallic Compounds / pharmacology*
  • Oxidation-Reduction
  • Structure-Activity Relationship
  • Triple Negative Breast Neoplasms / drug therapy*
  • Triple Negative Breast Neoplasms / pathology
  • Tumor Cells, Cultured

Substances

  • Ferrous Compounds
  • Indolequinones
  • Organometallic Compounds
  • ferrocifen
  • quinone methide